Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,841.77 -35.28 (-0.45%) Bitcoin USD
64,998.14 +2,268.16 (+3.62%) CMC Crypto 200
1,341.94 +29.31 (+2.29%)
Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.4000 |
| Open | 1.3900 |
| Bid | 1.4500 x 2300 |
| Ask | 1.4800 x 4600 |
| Day's range | 1.2900 - 1.5050 |
| 52-week range | 1.2500 - 14.5500 |
| Volume | |
| Avg. volume | 9,626,717 |
| Market cap | 391.21M |
| Beta (5Y monthly) | 1.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2100 |
| Earnings date | 30 Apr 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.46 |
Simply Wall St.Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
Market forces rained on the parade of Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders today, when...
ZacksPacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.
PR NewswirePacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million
© 2024 Yahoo. All rights reserved.